Write in a clean editor, then format for Movement Disorders Clinical Practice in one click — DocuGuru applies the official Wiley template with author–year references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Movement Disorders Clinical Practice is a peer-reviewed journal published by Wiley, covering Neurological disorders and treatments, Parkinson's Disease Mechanisms and Treatments, Genetic Neurodegenerative Diseases.
| Publisher | Wiley |
|---|---|
| Reference style | Author–year (Chicago) Author–year — (Smith, 2023) in the text Smith, Ada, Ben Jones, and Cara Lee. 2023. "A Representative Article Title." Movement Disorders Clinical Practice 12 (3): 45–58.
Formats any DOI in Movement Disorders Clinical Practice style. No sign-up. |
| Publishes research in | Neurological disorders and treatments Parkinson's Disease Mechanisms and Treatments Genetic Neurodegenerative Diseases Botulinum Toxin and Related Neurological Disorders Glycogen Storage Diseases and Myoclonus |
| ISSN | 2330-1619 |
| Citation impact (2-yr) | 1.77 |
| h-index | 59 |
| i10-index | 757 |
| Total citations | 26,230 |
| Article processing charge | $3,090 |
| Top institutions publishing here | University College London |
| Journal website | onlinelibrary.wiley.com |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
There has been a steadily growing armamentarium of drugs for the symptomatic treatment of Parkinson's disease (PD). Consequently, as various various pharmaceutical agents are used, it has become more difficult to perform and compare clinical trials with different medication regimens. Given that levodopa remains the gold standard treatment, conversion factors have been proposed to calculate…
Abstract Background The Movement Disorder Society‐Sponsored Revision of the Unified Parkinson's Disease Rating Scale ( MDS ‐ UPDRS ) is a commonly used tool to measure progression in patients with Parkinson's disease ( PD ). Longitudinal changes in MDS ‐ UPDRS scores in patients with de novo PD have not been established. The objective of…
BACKGROUND: The cause of PD at present remains unknown. A number of epidemiological studies have been conducted across the globe to ascertain the disease burden and the possible risk factors. In this review, we analyze the various studies from East and West with an aim to observe the important similarities and differences in the disease…
BACKGROUND: The study of complex neurodegenerative diseases is moving away from hypothesis-driven biological methods toward large scale multimodal approaches, requiring standardized collaborative efforts. Enroll-HD exemplifies such an integrated clinical research platform, designed and implemented to meet the research and clinical needs of Huntington's disease (HD). The aim of this study was to describe the unique…
Abstract Background The majority of patients with Parkinson's disease ( PD ) have handwriting abnormalities. Micrographia (abnormally small letter size) is the most commonly reported and easily detectable handwriting abnormality in patients with PD . However, micrographia is perhaps the tip of the iceberg representing the handwriting abnormalities in PD . Digitizing tablet technology, which…
